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HDAC41 has been implicated to play a role in cell growth control. In this report, we
demonstrate that YY1 was able to suppress NCI-H460 cell senescence through regulating the expression of
p16INK4a, a cyclin-dependent kinase inhibitor. We also show that YY1 participated in the repression of
p16INK4a expression in 293T cells through an epigenetic mechanism involving histone acetylation
modiﬁcation. Speciﬁcally, HDAC3 and HDAC4 inhibited the p16INK4a promoter activity. The chromatin
immunoprecipitation (ChIP) assays veriﬁed that HDAC3 and HDAC4 were recruited to p16INK4a promoter by
YY1. Moreover, co-immunoprecipitation assays revealed that these three protein factors formed a complex.
Furthermore, knockdown of these factors induced cell enlargement and ﬂattened morphology and
signiﬁcantly increased the SA-β-gal activity, a biochemical marker of cell senescence. Overall, data from
this study suggest that YY1, HDAC3 and HDAC4 restrained cell senescence by repressing p16INK4a expression
through an epigenetic modiﬁcation of histones.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionThe transcription factor YY1 (Yin Yang 1) is a ubiquitous, highly con-
served zinc ﬁnger transcription factor [1–3] that activates or represses
several different eukaryotic genes, among which are the c-Myc, c-Fos,
β-casein, β-actin, interleukin-3 and -5, and IFN-γ genes, aswell as some
viral promoters [3–7]. In support of the hypothesis that the actions of
YY1 are controlled by protein–protein interactions, a wide variety of
transcription factors have been shown to associatewithYY1, such as Sp1
[8], c-Myc [9] andC/EBP [10]. Subsequently, itwas found that thehistone
deacetylasesHDAC1,HDAC2andHDAC3could also bindYY1 and repress
transcription when targeted to promoters [11–14]. We have recently
demonstrated by using ChIP assays that histone deacetylase HDAC4was
recruited by YY1 to the interleukin-5 promoter and repressed the
transcription activity of the gene [15]. Many other proteins have been
reported to interact with YY1, such as p300, PCAF [13] and CBP [16],
whichpossess the histone acetyltransferase (HAT) activity. It is therefore
appealing to speculate that YY1 may activate transcription by the
recruitments of HAT proteins. Conceivably, the selective binding of YY1
with either HAT(s) or HDAC(s) determines whether it will mediate the
activation or repression of transcription of a given gene.d at Institute of Genetics and
treet, Changchun 130024, P.R.
. J. Lu, The Key Laboratory of
iversity, 5268 Renmin Street,
q705@nenu.edu.cn (B. Huang).
l rights reserved.The role of protein acetylation in the transcriptional control has
been extensively studied and is generally considered a major step
toward gene expression [17]. Two categories of enzymes with antag-
onistic activities, i.e., histone acetyltransferases (HATs) and histone
deacetylases (HDACs), contribute substantially to the control of gene
transcription through modiﬁcations of the acetylation state of core
histones, and in cases, the transcription factors [18]. In general,
histone hyperacetylation correlates with gene activation, whereas
histone deacetylation is associated with gene silencing [19].
The p16INK4a (hereafter p16), a tumor suppressor protein, functions
as an inhibitor of Cdk4 and Cdk6, the cyclin-dependent kinases that
initiate the phosphorylation of the retinoblastoma protein (pRb) [20].
pRb is a corepressor that binds several E2F family transcription factors
to silence a host of genes required for cell cycle advancement from G1
to S-phase. Thus, p16 has the capacity to arrest the cell cycle in G1, and
one of its physiological roles appears to be to induce irreversible
growth arrest characteristic of replicative senescence [21]. Recently,
studies by Brachen et al. implicated that the depletion of some
polycomb group proteins, such as EZH2, SUZ12 and BMI1, activated
p16 transcription and promoted cell senescence [22]. Also, Seligson
et al. reported that expression of YY1 correlated with the resistance to
immune-mediated apoptosis [23]. Whether YY1, as a polycomb group
protein, participates in cell senescence has not been elucidated. In this
report, we present experimental data showing that knockdown of YY1
by a speciﬁc siRNA vector (YY1i) increased expression of p16 and
induced cell senescence. Moreover overexpression of HDAC3 and
HDAC4 resulted in the repression of p16 expression. We also provide
evidence that HDAC3 and HDAC4 were recruited to p16 promoter by
Fig. 1. Knockdown of endogenous YY1 enhanced NCI-H460 cell senescence. (A)Western
blotting analysis of the YY1 protein in NCI-H460 cells transfected with YY1i vector or
YY1 expression vector. The pcDNA3.1 empty vector and an irrelevant siRNA vector were
used as controls. (B) YY1 restrained cell senescence. NCI-H460 cells transfected with
YY1 or YY1i vectors were lysed and tested for the SA-β-gal activity, using ONPG as
substrate at pH6.0. The controls were the pcDNA3.1 empty vector and an irrelevant
siRNA vector. ⁎⁎Pb 0.01, ⁎Pb 0.05, (n=3). (C) Representative photomicrographs of the
SA-β-gal staining at day 7 post YY1i transfection. The irrelevant siRNA vector was used
as the control.
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tions among YY1, HDAC3 and HDAC4 in p16 transcriptional inhibition
and their effects on cell senescence.
2. Materials and methods
2.1. Cell culture, transfection and luciferase reporter assay
NCI-H460 and 293T cells were maintained in IMDM medium supplemented with
10% FBS, 100 mg/ml penicillin and 100 mg/ml streptomycin in a humidiﬁed atmosphere
containing 5% CO2 at 37 °C. Transient transfection of 293T cells and NCI-H460 cells was
performed using the conventional calcium phosphate–DNA precipitation method and
Fu GENE HD transfection reagent (Roche), respectively. Twenty-four hours after the
transfection of the expression vectors, or 48 h after transfection of RNAi vectors, cells
were harvested for luciferase reporter activity, RT-PCR, Western or ChIP assays.
Transfected cells were analyzed for luciferase reporter activity using a Promega dual-
luciferase reporter assay system. The Renilla luciferase control plasmid pREP7-RLuc was
co-transfected in each experiment for normalization. All the results represent the
means±S.D. based on at least three independent experiments.
2.2. Plasmid constructs
The p16 promoter reporter (−869 to +1 bp from the ATG translation initiation site)
ligated to the luciferase reporter gene (pGL2 basic, Promega) was provided by Dr. E.
Hara (Imperial Cancer Research Fund Laboratories, London, U.K.). Plasmids expressing
human HDAC1–6 (fused to the FLAG-epitope) were gifts from Dr. W.C. Greene
(Gladstone Institute of Virology and Immunology, San Francisco, CA, USA) and Dr E. Seto
(H. Lee Mofﬁtt Cancer Center and Research Institute, Tampa, FL, USA). YY1 was kindly
supplied by Dr. E. Bonneloy (Regulation de la. Transcription et Maladies Genetiques,
CNRS UPR 2228, Universite Rene Descartes, France). The plasmids expressing human
HDAC4 (fused to the GFP-epitope) were generously provided by Dr. R. Bassel-Duby
(Department of Molecular Biology, University of Texas Southwestern Medical Center,
Dallas, TX 75390, USA).
2.3. RNA extraction and RT-PCR
Total cellular RNAwas extracted from the 293T cells according to the Promega Total
RNA Isolation System manual. RNA was re-suspended in RNase-free water and
quantitated by spectrophotometry before being reverse transcribed. PCR products
were resolved in 2% agarose gel. The p16 primer pairs were: sense 5′-ttcctggacacgctggt-
3′ and antisense 5′-caatcggggatgtctgag-3′. The β-actin primer pairs were: sense 5′-
tcgtgcgtgacattaaggag-3′ and antisense 5′-atgccagggtacatggtggt-3′. The number of
cycles of PCR ampliﬁcation was 25 for the β-actin, and 30 for the p16 gene.
2.4. Chromatin immunoprecipitation (ChIP)
The protocol for chromatin immunoprecipitation (ChIP) was described previously
[24]. Brieﬂy, 1×106 cells were treated with 2% formaldehyde in IMDM medium for
10 min at 37 °C to crosslink protein–DNA. To stop the reaction glycine (125 mM ﬁnal)
was added. After washed 4 times with cold PBS, cells were lysed by incubating in
nucleus lysis buffer. The lysate was sonicated with a Uibra cell TM-130 sonicator. After
centrifugation at 12000 rpm for 10 min, the supernatant was diluted 1:10 in ChIP
dilution buffer. The chromatin solution was precleared with 50 μl of protein A-agarose
beads (Upstate Biotechnology). The soluble fraction was collected and 5 μg of anti-
acetyl-histone H3 (Upstate Biotechnology), anti-acetyl-histone H4 (Upstate Biotechnol-
ogy), anti-YY1 (Santa Cruz, sc-1703) or anti-Flag (Sigma, F3165) antibodies was added.
After immunoprecipitation, the precipitated complexes were collected by adding 60 μl
of protein A-agarose beads. After washing, freshly prepared elution buffer (1% SDS, 0.1M
NaHCO3) was added, and the crosslinking was reversed at 65 °C for 4 h. DNA was
recovered by Proteinase K digestion, phenol/chloroform extraction, and ethanol
precipitation. For re-ChIP, the immuno-complexes were eluted by adding 100 ml re-
ChIP elution buffer (10 mM DTT) after washing for 30 min at room temperature with
rotation. The supernatant was diluted 1:20 in ChIP dilution buffer and the antibody
against the second protein of interest was added, and following treatment as indicated
above. Samples were analyzed by PCR. The sequences of the primers used were: P1
sense 5′-agtttcgctcttgtctcccag-3′, antisense 5′-atggcgaaaccctgtctctac-3′; P2 sense 5′-
agacagccgttttacacgcag-3′, antisense 5′-caccgagaaatcgaaatcacc-3′; and P3 sense 5′-
taggaaggttgtatcgcggagg-3′, antisense 5′-caaggaaggaggactgggctc-3′ [25]. The locations
of P1, P2 and P3 at the p16 promoter are illustrated in Fig. 2F. The number of cycles of
PCR ampliﬁcation was 30 for the input samples, 33 for the RNAi vector transfected
samples and 35 for the expression vector transfected samples. All the experiments were
repeated three times, and one of the representative results is shown in the text.
2.5. Western blot and co-immunoprecipitation (Co-IP) assays
NCI-H460 and 293T cells were harvested after transfection. 1×106 cells were
digested and lysed in the lysis buffer for 30 min at 4 °C. Total cell extracts were
separated in 12% SDS-polyacrylamide gel electrophoresis (PAGE), and then transferred
to a polyvinylidene ﬂuoride membrane. The membrane was incubated with anti-p16
(Santa Cruz, sc-468), anti-Flag, anti-YY1, anti-HDAC3 (Santa Cruz, sc-11417), anti-HDAC4 (Santa Cruz, sc-11418) or anti-β-actin (Sigma, A1978) antibodies, and visualized
by using the Chemiluminescent Substrate method with the SuperSignal West Pico kit
provided by Pierce Co. β-actin was used as an internal control for normalizing the
loading materials.
Co-precipitation was performed in 293T cells. The 293T cells were incubated with
DSP for 30 min, and then lysed in Buffer I (50 mM Tris–HCl, pH7.5, 150 mM NaCl, 1%
NP40, 0.05% sodium deoxycholate and protease inhibitors). Total cell extracts were
precleared with 40 μl Protein A-agarose at 4 °C for 1 h. The supernatant was incubated
with the anti-YY1 and anti-GFP antibodies (Upstate, 06-896) with gentle shaking for 1 h
at 4 °C followed by the addition of 40 μl of Protein A-agarose and incubated for another
3 h. The beads were re-suspended in 100 μl of 2× loading buffer and boiled for 10 min.
The proteins were separated on a 12% SDS-PAGE gel and then transferred to
polyvinylidene ﬂuoride membrane for immunoblotting detection with anti-YY1 or
anti-GFP antibodies.
2.6. RNA interference (RNAi)
The target sequence for YY1 RNAi was 5′-gagcagaagcaggtgcaga-3′ [26], and that for
HDAC4 was 5′-cgtcaacatggctttcacc-3′ [18]. Oligonucleotides that represent small
hairpin RNAs (shRNAs) targeting these sequences were designed and cloned into the
pSilencer2.0-U6 vector (Ambion) between BamHI and HindIII restriction sites according
to the manufacture's instructions. The HDAC3i vector was constructed previously [27].
2.7. Immunoﬂuorescence staining
The treated 293T cells were washed twice in PBS, ﬁxed with 4% paraformaldehyde
for 15 min, permeabilized with 0.2% Triton X-100 at room temperature and then
quenched in ice-cold PBS. After blocking with 5% BSA, collected cells were incubated
with rabbit anti-YY1 antibody for 1 h and stained with TRITC-conjugated goat anti-
rabbit secondary antibody (Zhongshan, China) for 45 min at 4 °C. Cells were examined
under a ﬂuorescence microscope (Nikon, Japan) and the images were collected at ×20
magniﬁcation with appropriate ﬁlters.
2.8. Senescence-associated galactosidase activity assay
Cells were lysed in reporter lysis buffer after transfection for 7 days. Cell lysates
containing equal amounts of protein were diluted in equal volumes of 2× assay buffer
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100 μl 2-mercaptoethanol in 200 mM phosphate buffer (pH 6.0), and incubated at 37 °C
for 4 h. The absorbance at 420 nmwas measured after the addition of an equal volume
of 1 M Na2CO3. All the results represent the means±S.D. based on at least three
independent experiments.
NCI-H460 cells were transfected with the YY1siRNA, HDAC3siRNA or HDAC4-
siRNA vectors, or an irrelevant siRNA vector as the control. At day 7 after transfection,
cells were processed using a Senescence β-Galactosidase Staining Kit (Cell Signaling
Technology). Cells were examined under a ﬂuorescence microscope (Nikon, Japan)
and the images were collected at ×10 magniﬁcation with appropriate ﬁlters. These
experiments were repeated three times, and one of the representative results is
shown.
2.9. Electrophoretic mobility shift assay (EMSA)
Biotin end-labeled sense and antisense oligonucleotides covering −544/−55 bp of
the p16 promoter were: 5′-gaagccatactttccctatgacaccaaacaccccgattcaatttggcagtta-3′
(−544 bp/−493 bp); 5′-gggggagcgcggctgggagcagggaggccggagggcggtgtggggggcaggt-3′
(−401 bp/−349 bp); 5′-gggaggagcccagtcctccttccttgccaacgctggctctggcgagggctgc-3′
(−348 bp/−297 bp); 5′-gagacccaacctggggcgacttcaggggtgccacattcgctaagtgctcgga-3′
(−275 bp/−224 bp); and 5′-aagaggaggggctggctggtcaccagagggtggggcggaccgagt-3′
(−99 bp/−55 bp). The oligonucleotides were labeled using a biotin 3′-end labeling kit
following the manufacturer's instructions (Pierce), respectively, and then annealed to
generate the double-stranded probes. EMSA was performed by pre-incubating 5 μg of
nucleus extract in 2 μg poly-dI:dC, 2 μl binding buffer on ice for 10 min. Twenty-ﬁve
fmol biotin-labeled double-stranded probe was added to the mix and incubated on ice
for another 15 min. DNA/protein complexes were resolved in a 6% polyacrylamide gel
and analyzed according to the EMSA kit instructions (Pierce). Supershift assays were
done by adding 1 μg of anti-YY1 antibody after DNA/protein incubation.Fig. 2. YY1 repressed p16 expression to restrain cell senescence. (A) YY1 restrained senesc
staining at day 7 after YY1i, or YY1i plus p16i transfection. An irrelevant siRNA vector was u
protein in NCI-H460 cells transfected with YY1 or YY1i vector. (C) Western blot analysis o
pcDNA3.1 empty vector and an irrelevant siRNAvector as the control. (D) YY1 inhibited p16 p
p16 promoter activity was examined by luciferase reporter assay. The controls were the pcD
endogenous p16mRNA. 293Tcells were transiently transfectedwith YY1 or YY1i vector. Total
used as an internal control. (F) Diagram of the 5′-ﬂanking region of p16 gene. Lines (P1–3) in
(G) Binding of YY1 on p16 promoter. ChIP assays with anti-YY1 antibody in 293T cells transfe
from 293T cells were incubated with 5 biotin-labeled oligonucleotides corresponding to regio
as control (lanes 1, 4, 7, 10 and 13). Lanes 2, 5, 8, 11 and 14 were the reaction with nuclear e3. Results
3.1. RNAi-induced silencing of endogenous YY1 enhanced NCI-H460 cell
senescence
To determine whether YY1 affects cell senescence, we assayed the
senescence-associated β-galactosidase (SA-β-gal; pH6.0) activity and
SA-β-gal staining, a biomarker tightly associated with cell senescence
in human cells [28,29]. Senescent human ﬁbroblasts express a β-Gal,
an endogenous product that can be detected in single cells by X-Gal at
pH 6.0, by forming a local blue precipitate upon cleavage [29]. We ﬁrst
constructed the siRNA vector speciﬁc to YY1 (YY1i) to knockdown the
endogenous YY1 expression. The inhibitory efﬁciency of YY1i on
endogenous YY1 expression in NCI-H460 cells was veriﬁed byWestern
blotting, and the exogenous expression of the YY1 vector was also
measured (Fig. 1A). Next, the transfected NCI-H460 cells were lysed
and assayed for the SA-β-gal activity. As shown in Fig. 1B, a 1.5-fold
increase in SA-β-gal activity was seen after 7 days of YY1i transfection,
while overexpression of YY1 led to a reverse effect. In addition, cells
transfected with YY1i exhibited phenotypic changes that resembled
those observed in the cells undergoing replicative senescence. These
changes include increased SA-β-gal staining, ﬂattened cell morphol-
ogy, and enlarged cell size (Fig. 1C). Together, these data implicated
that YY1 played a role in restraint of cell senescence.ence of NCI-H460 cells through p16. Representative photomicrographs of the SA-β-gal
sed as the control. (B) YY1 repressed p16 protein expression. Western blots of the p16
f the YY1 protein in 293T cells transfected with YY1i vector or YY1 expression vector,
romoter activity. 293T cells were transiently transfected with YY1 or YY1i vector, and the
NA3.1 empty vector and an irrelevant siRNA vector. ⁎⁎Pb0.01, (nb3). (E) YY1 repressed
RNAwas isolated, reverse transcribed and p16mRNAwasmeasured by PCR. β-actinwas
dicate the three regions of p16 promoter ampliﬁed by speciﬁc primers in ChIP analysis.
cted with YY1 expression vector. (H) YY1 interacted with p16 promoter. Nuclear extracts
n −544 to −55 bp of the p16 promoter. The reactions without nuclear extracts were used
xtracts. Anti-YY1 antibody was added for super-shift study (lanes 3, 6, 9, 12 and 15).
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Since p16 has been implicated to play a pivotal role in cell senes-
cence, we sought to determine whether YY1 induced cell senescence
through p16. We used a p16siRNA vector (p16i) to knockdown the
endogenous p16 expression [30]. Apparently, compared with the cells
transfected with YY1i alone, co-transfection of cells with YY1i and p16i
vectors failed to induce cell senescence (Fig. 2A).Westernblotting assays
demonstrated that the p16 protein expression was decreased upon
overexpression of YY1, while it was enhanced by knockdown of the
endogenous YY1 in NCI-H460 cells (Fig. 2B). A previous study
demonstrated that the HDAC inhibitor butyrate (NaB) was able to
increase theexpressionof p16 inNCI-H460cells [31]. To look further into
the roles of YY1 in regulation of p16 expression, we tested the effect of
YY1onp16expression in293Tcells. First,wemeasured theexpressionof
YY1 in 293T cells by using Western blotting (Fig. 2C). We then showed
that overexpression of YY1 inhibited the p16 promoter activity, while
knockdown of the endogenous YY1 expression by YY1i increased the
activity of p16 promoter (Fig. 2D). Also, it can be seen from Fig. 2E that
the p16 mRNA level was decreased upon the overexpression of YY1, but
increased by the knockdown of the endogenous YY1. Additionally, we
designed a series of primer coordinates to the three regions in p16
promoter for ChIP assays (Fig. 2F). P1 locates at the far upstream of p16
promoter (−1800 bp) as a negative control, whereas P2 and P3 locate at
the downstream of p16 promoter (−800 bp and −300 bp), representing
the important regulatory regions of p16 gene. As can be seen in Fig. 2G,
the ChIP data revealed that YY1 was enriched at the p16 promoter (P3)
upon the overexpression of YY1. Furthermore, Electrophoretic Mobility
Shift Assays (EMSA) was performed to conﬁrm the ChIP results. The
EMSA results shown in Fig. 1H revealed that although the nuclear
extracts could signiﬁcantly retard the probes 2, 3 and 4 (lanes 8, 11 and
14), only probe 3 was supershifted by anti-YY1 antibody (lane 9). This
demonstrated that YY1 was able interact with the p16 promoter,
conﬁrming the ChIP results of YY1 enrichment at the p16 promoter (P3)Fig. 3.HDAC3 and HDAC4 downregulated p16 expression. (A) HDACs downregulated the p16
were co-transfected into 293T cells. Luciferase activity was determined 24 h after transfec
⁎⁎Pb0.01, ⁎Pb0.05, (n=3). (B)Western blots of the HDAC3/4. The inhibitory efﬁciency of HDA
HDAC4 inhibited the p16 promoter activity. 293T cells were transfected with: 1 μg HDAC3 or
the pcDNA3.1 empty vector and an irrelevant siRNA vector. ⁎⁎Pb0.01, (n=3). (D) Quantitative
HDAC4i vector. Total RNA was isolated, reverse transcribed and p16 mRNA was measured bupon the overexpression of YY1 (Fig. 2G). These results further support
the notion that YY1 participates in cell senescence through inhibiting
p16 transcription.
3.3. HDAC3 and HDAC4 downregulated p16 expression
In a previous report, we described that the histone acetyltransferase
p300 promoted p16 expression [30], implying that HDAC(s) may also be
involved inp16 regulation as antagonistic enzyme(s) toHATs. To test this
and to determine which HDACs participate in the inhibition of p16
expression, 293T cells were transfected with p16 promoter reporter,
together with the expression vectors of HDAC1-6. Of the six HDACs
tested, HDAC3 and HDAC4were found to exhibitmuchmore prominent
effects onp16 repression, comparedwith otherHDACs (Fig. 3A).We then
usedHDAC3i and HDAC4i vectors to knockdown the HDAC3 and HDAC4
expression, and theWestern blotting data in Fig. 3B conﬁrmed that the
expression of HDAC3 and HDAC4 was decreased by this RNAi protocol.
Next, the transfection experiments revealed that the siRNA-mediated
silencing of endogenous HDAC3 and HDAC4 activated the p16 promoter
activity, while overexpression of HDAC3 and HDAC4 inhibited p16
promoter activity (Fig. 3C). Moreover, the p16 mRNA level was also
decreased upon HDAC3 and HDAC4 overexpression, but increased by
knockdownofHDAC3andHDAC4 (Fig. 3D). These results implicated that
HDAC3 and HDAC4 inhibited p16 transcription.
3.4. HDAC3 and HDAC4 downregulated p16 to suppress cell senescence
First, the inhibitory efﬁciency of HDAC3i and HDAC4i on endogen-
ous HDAC3 and HDAC4 expression in NCI-H460 cells was veriﬁed
by Western blotting (Fig. 4A). And then we showed that, as expected,
the p16 protein level was decreased by overexpression of HDAC3
and HDAC4, while it was enhanced by knockdown of these HDACs in
NCI-H460 cells (Fig. 4B and C). Also, knockdown of the endogenous
HDAC3 and HDAC4 expression by RNAi increased the SA-β-gal activity,promoter activity. One μg of the p16 reporter vector, together with 1 μg of each HDAC1–6
tion and normalized to the Renilla activity. The pcDNA3.1 vector was used as control.
C4i and HDAC3i on HDAC4 and HDAC3 proteins was measured in 293T. (C) HDAC3 and
5 μg HDAC3i vector (Left), 1 μg HDAC4 or 5 μg HDAC4i vector (Right). The controls were
estimation of p16 mRNA level. Cells were transfected with HDAC3/4 vectors, HDAC3i or
y RT-PCR. β-actin was used as an internal control.
Fig. 5. HDAC3/4 induced histone hypoacetylation at the p16 promoter. (A) ChIP data showing the HDAC3/4 recruitments on p16 promoter. 293T cells were crosslinked with
formaldehyde 24 h after transfectionwith HDAC3-Flag and HDAC4-Flag vectors. DNAwas sheared and immunoprecipitated with anti-Flag antibody. PCR products were resolved on a
1.5% agarose gel. Input indicates the DNA prior to immunoprecipitation. (B–E) ChIP assays for the detection of the presence of acetylated histone H3 and H4 on p16 promoter. 293T
cells were transfectedwith HDAC3 (B), HDAC4 (C), HDAC3i (D), or HDAC4i (E) vector. Cells were harvested, DNAwas sheared and immunoprecipitatedwith anti-acetylated histone H3
antibody and anti-acetylated histone H4 antibody. (F) Data of re-ChIP assays. The 293T cells were transfected with HDAC3-Flag or HDAC4-Flag, and the samples were
immunoprecipitated with anti-Flag antibody as the ﬁrst antibody. Then the samples were immunoprecipitated with the second antibody, anti-acetylated histone H3 antibody or anti-
acetylated histone H4 antibody.
Fig. 4. HDAC3 and HDAC4 repressed p16 expression to affect cell senescence. (A) Western blotting analysis of the HDAC3 and HDAC4 proteins in NCI-H460 cells transfected with
HDAC3i and HDAC4i vectors. An irrelevant siRNA vector was used as the control. (B–C) HDAC3/4 inhibited p16 expression. Western blots of the p16 protein in NCI-H460 cells
transfectedwith HDAC3/4, HDAC3i or HDAC4i vector (B), and with HDAC3/HDAC4, or HDAC3i/HDAC4i (C). (D) HDAC3/4 suppressed cell senescence through repressing p16. NCI-H460
cells transfected with HDAC3, HDAC4 or HDAC3i, HDAC4i vectors were lysed and tested for the SA-β-gal activity, using ONPG as substrate at pH 6.0. The control was the pcDNA3.1
empty vector and an irrelevant siRNA vector. ⁎Pb0.05, (n=3). (E) Knockdown of HDAC3 and HDAC4 increased the SA-β-gal activity of NCI-H460 cells. Representative
photomicrographs of the SA-β-gal staining at day 7 post transfection (HDAC3i, HDAC4i, or p16i) are presented. An irrelevant siRNA vector was used as the control.
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(Fig. 4D). Furthermore, the cell senescencewas also conﬁrmedbyusing
the SA-β-gal staining assay of the cells. As evidenced in Fig. 4E,
knockdown of HDAC3 and HDAC4 enhanced the SA-β-gal staining,
while co-transfection of cells with HDAC3i/4i and p16i vectors failed to
induce cell senescence. These results strongly suggest that HDAC3 and
HDAC4 implemented their cell senescence restraint role via inhibition
of p16 transcription.
3.5. HDAC3 and HDAC4 were present at the p16 promoter to induce
histone hypoacetylation
Our ChIP experiments with anti-Flag antibody revealed that both
HDAC3 and HDAC4 were enriched at the downstream regions of p16
promoter (P2 and P3) upon their overexpression (Fig. 5A). Addition-
ally, ChIP assays with anti-acetylated histone H3 and H4 antibodies
demonstrated that the acetylation level of histone H4 was reduced by
exogenous expression of HDAC3 at P2 and P3 regions, whereas the
acetylation level of H3 was not affected (Fig. 5B). Meanwhile, the
acetylation level of histone H3 was reduced by exogenous expression
of HDAC4 at P2 and P3 regions, while the acetylation of H4 was not
affected (Fig. 5C). Contrarily, HDAC3i and HDAC4i enhanced the
acetylation levels of both H3 and H4 (Fig. 5D and E). Re-ChIP assaysFig. 6. The interactions among YY1, HDAC3 and HDAC4. (A) Co-localization of YY1 and HDAC3
GFP plus YY1. Cells were ﬁxed in formaldehyde and stained with anti-YY1 antibody followed b
immunostained in red and HDAC3/4 in green. The nuclei were counterstained with Hoechs
(B) Co-IP assays for association of HDAC3/4 with YY1. The cell nuclear extracts were prepared
using immunoblotting with anti-YY1 and anti-HDAC4 antibodies (upper). The nuclear extrac
with anti-YY1 and anti-GFP antibodies, and detected by the respective antibodies (lower). Inp
increased the activity of p16 promoter. One μg of p16 reporter vector with 5 μg of YY1i and
promoter activity was examined by luciferase reporter assay. The control was an irreleva
expression. Western blots of the p16 protein in NCI-H460 cells transfected with YY1i and H
HDAC4 stimulated NCI-H460 cell senescence. Representative photomicrographs of the S
An irrelevant siRNA vector was used as the control.indicated that the acetylation levels of histone H4 and H3 at P2 and P3
regions of p16 promoter, were reduced upon the exogenous expres-
sion of HDAC3 and HDAC4, respectively (Fig. 5F). These experimental
data clearly indicated that HDAC3 and HDAC4 played an important
role in p16 repression via inducing histone deacetylationmodiﬁcation.
3.6. The interactions among YY1, HDAC3 and HDAC4
The results described above implicated that HDAC3 and HDAC4,
together with YY1, were able to inhibit p16 gene expression. Next, we
sought to investigate whether a physical interaction among these
factors exists. First, immunoﬂuorescence microscopy demonstrated
that HDAC3 and YY1, as well as HDAC4 and YY1, were co-localized in
cell nuclei (Fig. 6A). Then, we investigated the physical interactions
among these protein factors by using co-immunoprecipitation (Co-IP)
assays. The nuclear extracts from the 293T cells were immunopreci-
pitated by anti-YY1, anti-HDAC3 and anti-HDAC4 antibodies, and
detected in immunoblotting with anti-YY1 and anti-HDAC4 anti-
bodies, respectively (Fig. 6B, upper). Meanwhile, the nuclear extracts
from the 293T cells transfected with HDAC3-GFP and HDAC4-GFP
expression vectors were immunoprecipitated by anti-GFP and anti-
YY1 antibodies, and detected in immunoblotting with respective
antibodies (Fig. 6B, lower). The Co-IP results suggested that HDAC3,/4. 293T cells were plated onto glass slides and transfected with HDAC3-GFP or HDAC4-
y a TRITC secondary antibody, and visualized under a ﬂuorescencemicroscope. YY1was
t 33342 (blue). The merged images were created with Simple PCI software (Cimaging).
and precipitatedwith anti-YY1, anti-HDAC3 and anti-HDAC4 antibodies, and detected by
ts from the cells transfected with HDAC3-GFP or HDAC4-GFP vectors were precipitated
ut: proteins prior to immunoprecipitation. (C) Knockdown of YY1 and HDAC3 or HDAC4
HDAC3i vectors, or with YY1i and HDAC4i, were transfected into 293T cells. The p16
nt siRNA vector. (D) Knockdown of YY1 and HDAC3 or HDAC4 increased p16 protein
DAC3i vectors, or with YY1i and HDAC4i vectors. (B) Knockdown of YY1 and HDAC3 or
A-β-gal staining at day 7 after YY1i and HDAC3i, or YY1i and HDAC4i transfection.
Fig. 7. HDAC3 and HDAC4were recruited to p16 promoter by YY1. (A–B) YY1 recruited HDAC3/4 to p16 promoter. Cells were transfected with YY1 (A), or with YY1i (B), together with
HDAC3-Flag or HDAC4-Flag vector. Samples were immunoprecipitatedwith anti-Flag antibody, and the precipitated DNAwas ampliﬁed using PCR. (C–D) ChIP assays for the detection
of acetylated histone H3 or H4 on p16 promoter. 293T cells were transfected with YY1 (C) and with YY1i (D). Cells were harvested, and DNA was sheared and immunoprecipitated
with anti-acetylated H3 and anti-acetylated H4 antibodies.
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transfection experiments revealed that the siRNA-mediated silencing
of endogenous YY1 and HDAC3 or HDAC4 activated the p16 promoter
activity (Fig. 6C). Western blotting assays demonstrated that the p16
protein expression was enhanced by knockdown of the endogenous
YY1 and HDAC3 or HDAC4 in NCI-H460 cells (Fig. 6D). Co-transfection
of cells with YY1i and HDAC3i or HDAC4i vectors induced cell
senescence (Fig. 6E). Thus, data presented above provided evidence
that YY1 together with HDAC3 and HDAC4 interacted and worked
coordinately to contribute to the repression of p16 expression.
3.7. HDAC3 and HDAC4 were recruited to p16 promoter by YY1
To determine whether HDAC3 and HDAC4 were recruited to p16
promoter by YY1, we examined the binding of HDAC3 and HDAC4 at
the p16 promoter regions, and the results showed the binding of
HDAC3 and HDAC4 was signiﬁcantly increased after YY1 overexpres-
sion (Fig. 7A), while they were reduced by knockdown of the
endogenous YY1 (Fig. 7B). Also, the ChIP data indicated that the
acetylation levels of H3 and H4were decreased by YY1 overexpression
(Fig. 7C), whereas they were increased by transfection of YY1i
(Fig. 7D), implicating that HDAC3/4 participated in repression of p16
by YY1. Thus, data presented above provide evidence that HDAC3 and
HDAC4 were recruited to p16 promoter via YY1.
4. Discussion
The putative role of YY1 in tumorigenesis has been supported by
its known interactions with the cell cycle regulators, such as Cyclin D,
p53 and c-myc [32]. It would not be surprising to see that deregulated
YY1 activity might serve as a central factor causing dysfunctional cell
proliferation and increased resistance to cell death. Thus, YY1 may act
as an initiator of tumorigenesis and may potentially serve both as a
diagnostic and a prognostic tumor marker [32]. Recent evidence
showed that inhibition of YY1 by YY1 siRNA sensitized the cells to
TRAIL apoptosis concomitantly with DR5 up-regulation [33,34]. Datafrom Affar et al. not only shed new light on the molecular basis for
YY1's roles in developmental and cellular functions, but also provided
insight into the general mechanisms controlling eukaryotic cell
proliferation, apoptosis, and differentiation [35]. Our results from
this study supported this notion by showing that overexpression of
YY1 decreased the SA-β-gal activity, while knockdown of the
endogenous YY1 expression by RNAi increased both the SA-β-gal
activity (Fig. 1B) and the SA-β-gal staining (Fig. 1C). Meanwhile, co-
transfection of cells with YY1i and p16i vectors failed to cause cell
senescence (Fig. 2A). A previous study by Brachen et al. implicated that
the depletion of some polycomb group proteins, such as EZH2, SUZ12
and BMI1, activated p16 transcription and promoted cell senescence
[22]. These authors also reported that polycomb proteins participated
in p16 transcription regulation and senescence induction by changing
the methylation status of lysine 9 of histone H3 at the p16 promoter
[22]. In this report, we showed that YY1, a member of polycomb group
proteins, restrained cell senescence by regulating p16 expression,
through an epigenetic mechanism involving histone acetylation
modiﬁcation. Presumably, the YY1 function described in this report
may represent the common feature of the polycomb proteins, similar
to those reported by Brachen et al.
YY1 is a multi-functional transcription factor that can act on the
genes' promoters, enhancers and initiator elements [36,37]. Here we
demonstrate that YY1 functioned as a repressor of the p16 expression.
We presented evidence that overexpression of YY1 decreased both the
p16 mRNA level (Fig. 2E) and p16 protein production (Fig. 2B), as well
as p16 promoter activity (Fig. 2D). These results showed that YY1
played a repression role in p16 expression. It has been suggested that
YY1 represses transcription through multiple mechanisms [32]. Most
frequently, these mechanisms involve the competition of YY1 with
activating factors in overlapping binding sites, thereby decreasing
promoter activity and resulting in transcriptional repression. Other
hypotheses include the negative regulation of YY1 on neighboring
promoter-bound activators [38]. The third model, and the most recent
one to emerge, suggests that YY1 recruits a corepressor or complex to
a promoter and that this corepressor either negatively affects other
1883X. Wang et al. / Biochimica et Biophysica Acta 1783 (2008) 1876–1883factors that are present, or alters the local chromatin structure to bring
about repression [3]. Corepressors that have attracted extensive
research interests in the area of chromatin modiﬁcation include
HDAC1, HDAC2, HDAC3 and HDAC4 [11–15]. In this study, we
identiﬁed that overexpression of YY1 resulted in an enrichment of
HDAC3 and HDAC4 on p16 promoter (Fig. 7A), suggesting that YY1
recruited HDAC3 and HDAC4 to p16 promoter. Our experimental
evidence also supports the important roles of HDAC activity of HDAC3/
4 in p16 expression repression (Fig. 5). It is likely that the inhibitory
function of YY1 on p16 gene expression ﬁts the model described by
Thomas and Seto [3], which involves the recruitment of corepressors
and chromatin modiﬁers to the gene promoter.
Data presented in this report demonstrate that both HDAC3 and
HDAC4 restrained cell senescence via inhibition of p16 gene transcrip-
tion (Fig. 4D and E). An early study revealed that the histone deacetylase
inhibitors Trichostatin A (TSA) and butyrate induced senescent-like
phenotype in MECL cells [39], indicating that acetylation of histones
participated in cell senescence. However, whether HDACs affect the cell
senescence has not been previously described. This report provided the
ﬁrst evidence that HDAC3 and HDAC4 played inhibitory roles in cell
senescence through repression of p16 transcription.
To conclude, we demonstrate in this report that themulti-functional
transcription factor YY1 is able to restrain cell senescence through
inhibition of p16expression, and this process involves the recruitmentof
HDAC3 and HDAC4 to the p16 promoter by YY1. Moreover, we provide
experimental evidence that YY1,HDAC3andHDAC4 co-exist in the same
complex and work coordinately to contribute to the repression of p16
expression that in turn induces cell senescence.
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